Search

everythinglearnresearchcommunity

for

Search:↓

Enobosarm significantly increased muscle mass and improved physical function in elderly men and postmenopausal women without serious side effects.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

Estrogen therapy can reduce skin aging but has cancer risks.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

SARMs show promise but need more evidence to prove they're better than traditional androgens.

Anabolic steroids can build muscle and strength but have risks and need more research on their clinical benefits and side effects.

Targeting androgen receptors shows promise for treating triple-negative breast cancer, but more research is needed.

GTx-024 and Danazol affect the uterus like DHT, while GTx-007 has little impact.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

Understanding how androgens and their receptors work can lead to improved treatments for skin diseases.

Clinicians should use social and prescription data to track trends in performance-enhancing drug use.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

RU 58841 may treat acne, hair loss, and excessive hair growth.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Certain progesterone derivatives can inhibit enzymes and reduce androgenic activity, potentially affecting prostate growth.

The more lipophilic the progesterone derivative, the better it binds to androgen receptors and has antiandrogenic effects.

Estrogens are key for bone growth spurts in both boys and girls and affect growth into adulthood.

Testosterone, progesterone, and levonorgestrel change enzyme levels related to fat production in hamster skin, which could affect skin oil and acne.

Avicennia Marina extract and avicequinone C can reduce hair loss hormone production and increase hair growth factors, suggesting they could be used to treat androgenic alopecia.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

Finasteride may cause kidney damage.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.